Effect of Simultaneous Nephrectomy on Perioperative Blood Pressure and Graft Outcome in Renal Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease.
10.4285/jkstn.2016.30.1.24
- Author:
Hyung Ah JO
1
;
Hayne Cho PARK
;
Hyunsuk KIM
;
Miyeun HAN
;
Jong Cheol JEONG
;
Kook Hwan OH
;
Jaeseok YANG
;
Hee Jung JEON
;
Tai Yeon KOO
;
Jongwon HA
;
Cheol KWAK
;
Young Hwan HWANG
;
Curie AHN
Author Information
1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. ondahl@eulji.ac.kr
- Publication Type:Original Article
- Keywords:
Autosomal dominant polycystic kidney;
Nephrectomy;
Kidney transplantation
- MeSH:
Blood Pressure*;
Graft Survival;
Humans;
Kidney;
Kidney Transplantation;
Nephrectomy*;
Perioperative Period;
Polycystic Kidney, Autosomal Dominant*;
Transplantation*;
Transplants*
- From:The Journal of the Korean Society for Transplantation
2016;30(1):24-30
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: For various reasons, kidney transplant recipients with autosomal dominant polycystic kidney disease (ADPKD) often undergo native nephrectomy in preparation for the transplantation. Simultaneous nephrectomy can result in hypotensive events perioperatively and affect transplant outcome adversely. Our aim was to evaluate the effect of simultaneous native nephrectomy (SNx) on perioperative blood pressure and graft outcome compared to non-nephrectomy (NNx) in renal transplant recipients with ADPKD. METHODS: Data regarding renal function and blood pressure were collected from 42 renal transplant recipients with ADPKD. The primary outcome was graft function over 1 year post-transplant. The secondary outcomes were patient and graft survival, postoperative hypotensive events, and blood pressure control. We compared units of anti-hypertensive medication used by transplanted ADPKD patients in the SNx and NNx groups. RESULTS: Patients with SNx during kidney transplantation showed similar rates of patient and graft survival and renal function. Although they had significantly more hypotensive events during the perioperative period (69.2% vs. 37.5% in NNx, P=0.045), no harmful influence on renal function was observed. No difference in mean blood pressure during the 1-year post-transplant period was observed between the two groups; however, the SNx group required fewer units of anti-hypertensive medication. CONCLUSIONS: SNx is a relatively safe procedure. Graft outcome in the SNx group was not inferior to that of the NNx group, and patients with SNx can have well-controlled blood pressure.
